{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:41:08Z","timestamp":1782866468453,"version":"3.54.5"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,11,25]],"date-time":"2011-11-25T00:00:00Z","timestamp":1322179200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1007\/s00417-011-1865-8","type":"journal-article","created":{"date-parts":[[2011,11,24]],"date-time":"2011-11-24T05:36:51Z","timestamp":1322113011000},"page":"603-610","source":"Crossref","is-referenced-by-count":24,"title":["Adverse events associated with intraocular injections of bevacizumab in eyes with neovascular glaucoma"],"prefix":"10.1007","volume":"250","author":[{"given":"Tomomi","family":"Higashide","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Murotani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Ohkubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhisa","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,11,25]]},"reference":[{"key":"1865_CR1","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/00006982-200603000-00016","volume":"26","author":"RL Avery","year":"2006","unstructured":"Avery RL (2006) Regression of retinal and iris neovascularization after intravitreal bevacizumab (Avastin) treatment. Retina 26:352\u2013354","journal-title":"Retina"},{"key":"1865_CR2","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1089\/jop.2007.0036","volume":"23","author":"ME Gheith","year":"2007","unstructured":"Gheith ME, Siam GA, de Barros DS, Garg SJ, Moster MR (2007) Role of intravitreal bevacizumab in neovascular glaucoma. J Ocul Pharmacol Ther 23:487\u2013491","journal-title":"J Ocul Pharmacol Ther"},{"key":"1865_CR3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/112067210801800214","volume":"18","author":"KV Chalam","year":"2008","unstructured":"Chalam KV, Gupta SK, Grover S, Brar VS, Agarwal S (2008) Intracameral Avastin dramatically resolves iris neovascularization and reverses neovascular glaucoma. Eur J Ophthalmol 18:255\u2013262","journal-title":"Eur J Ophthalmol"},{"key":"1865_CR4","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/j.ophtha.2008.02.026","volume":"115","author":"T Wakabayashi","year":"2008","unstructured":"Wakabayashi T, Oshima Y, Sakaguchi H, Ikuno Y, Miki A, Gomi F, Otori Y, Kamei M, Kusaka S, Tano Y (2008) Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases. Ophthalmology 115:1571\u20131580, 1580.e1-3","journal-title":"Ophthalmology"},{"key":"1865_CR5","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/IAE.0b013e3181679c0b","volume":"28","author":"JP Ehlers","year":"2008","unstructured":"Ehlers JP, Spirn MJ, Lam A, Sivalingam A, Samuel MA, Tasman W (2008) Combination intravitreal bevacizumab\/panretinal photocoagulation versus panretinal photocoagulation alone in the treatment of neovascular glaucoma. Retina 28:696\u2013702","journal-title":"Retina"},{"key":"1865_CR6","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1177\/112067210901900318","volume":"19","author":"V Gupta","year":"2009","unstructured":"Gupta V, Jha R, Rao A, Kong G, Sihota R (2009) The effect of different doses of intracameral bevacizumab on surgical outcomes of trabeculectomy for neovascular glaucoma. Eur J Ophthalmol 19:435\u2013441","journal-title":"Eur J Ophthalmol"},{"key":"1865_CR7","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1755-3768.2009.01648.x","volume":"88","author":"Y Saito","year":"2010","unstructured":"Saito Y, Higashide T, Takeda H, Ohkubo S, Sugiyama K (2010) Beneficial effects of preoperative intravitreal bevacizumab on trabeculectomy outcomes in neovascular glaucoma. Acta Ophthalmol 88:96\u2013102","journal-title":"Acta Ophthalmol"},{"key":"1865_CR8","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/bjo.2008.151472","volume":"93","author":"AL Moraczewski","year":"2009","unstructured":"Moraczewski AL, Lee RK, Palmberg PF, Rosenfeld PJ, Feuer WJ (2009) Outcomes of treatment of neovascular glaucoma with intravitreal bevacizumab. Br J Ophthalmol 93:589\u2013593","journal-title":"Br J Ophthalmol"},{"key":"1865_CR9","first-page":"964.e1","volume":"149","author":"Y Saito","year":"2010","unstructured":"Saito Y, Higashide T, Takeda H, Murotani E, Ohkubo S, Sugiyama K (2010) Clinical factors related to recurrence of anterior segment neovascularization after treatment including intravitreal bevacizumab. Am J Ophthalmol 149:964.e1\u2013972.e1","journal-title":"Am J Ophthalmol"},{"key":"1865_CR10","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1136\/bjo.2006.099598","volume":"90","author":"AE Fung","year":"2006","unstructured":"Fung AE, Rosenfeld PJ, Reichel E (2006) The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide. Br J Ophthalmol 90:1344\u20131349","journal-title":"Br J Ophthalmol"},{"key":"1865_CR11","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00417-007-0660-z","volume":"246","author":"L Wu","year":"2008","unstructured":"Wu L, Mart\u00ednez-Castellanos MA, Quiroz-Mercado H, Arevalo JF, Berrocal MH, Farah ME, Maia M, Roca JA, Rodriguez FJ, Pan American Collaborative Retina Group (PACORES) (2008) Twelve-month safety of intravitreal injections of bevacizumab (Avastin): results of the Pan-American Collaborative Retina Study Group (PACORES). Graefes Arch Clin Exp Ophthalmol 246:81\u201387","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1865_CR12","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1600-0420.2007.01067.x","volume":"86","author":"C Shima","year":"2008","unstructured":"Shima C, Sakaguchi H, Gomi F, Kamei M, Ikuno Y, Oshima Y, Sawa M, Tsujikawa M, Kusaka S, Tano Y (2008) Complications in patients after intravitreal injection of bevacizumab. Acta Ophthalmol Scand 86:372\u2013376","journal-title":"Acta Ophthalmol Scand"},{"key":"1865_CR13","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0161-6420(98)92782-8","volume":"105","author":"RC Tripathi","year":"1998","unstructured":"Tripathi RC, Li J, Tripathi BJ, Chalam KV, Adamis AP (1998) Increased level of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucoma. Ophthalmology 105:232\u2013237","journal-title":"Ophthalmology"},{"key":"1865_CR14","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10384-008-0645-4","volume":"53","author":"K Matsuyama","year":"2009","unstructured":"Matsuyama K, Ogata N, Jo N, Shima C, Matsuoka M, Matsumura M (2009) Levels of vascular endothelial growth factor and pigment epithelium-derived factor in eyes before and after intravitreal injection of bevacizumab. Jpn J Ophthalmol 53:243\u2013248","journal-title":"Jpn J Ophthalmol"},{"key":"1865_CR15","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3341\/kjo.2009.23.3.188","volume":"23","author":"TH Lim","year":"2009","unstructured":"Lim TH, Bae SH, Cho YJ, Lee JH, Kim HK, Sohn YH (2009) Concentration of vascular endothelial growth factor after intracameral bevacizumab injection in eyes with neovascular glaucoma. Korean J Ophthalmol 23:188\u2013192","journal-title":"Korean J Ophthalmol"},{"key":"1865_CR16","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.ajo.2007.03.007","volume":"143","author":"S Peters","year":"2007","unstructured":"Peters S, Heiduschka P, Julien S, Ziemssen F, Fietz H, Bartz-Schmidt KU, T\u00fcbingen Bevacizumab Study Group, Schraermeyer U (2007) Ultrastructural findings in the primate eye after intravitreal injection of bevacizumab. Am J Ophthalmol 143:995\u20131002","journal-title":"Am J Ophthalmol"},{"key":"1865_CR17","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/jcu.20652","volume":"38","author":"A Mete","year":"2010","unstructured":"Mete A, Saygili O, Mete A, Bayram M, Bekir N (2010) Effects of intravitreal bevacizumab (Avastin) therapy on retrobulbar blood flow parameters in patients with neovascular age-related macular degeneration. J Clin Ultrasound 38:66\u201370","journal-title":"J Clin Ultrasound"},{"key":"1865_CR18","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1755-3768.2009.01526.x","volume":"88","author":"P Bonnin","year":"2010","unstructured":"Bonnin P, Pournaras JA, Lazrak Z, Cohen SY, Legargasson JF, Gaudric A, Levy BI, Massin P (2010) Ultrasound assessment of short-term ocular vascular effects of intravitreal injection of bevacizumab (Avastin(\u00ae) ) in neovascular age-related macular degeneration. Acta Ophthalmol 88:641\u2013645","journal-title":"Acta Ophthalmol"},{"key":"1865_CR19","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1111\/j.1755-3768.2010.02075.x","volume":"89","author":"Y Toklu","year":"2011","unstructured":"Toklu Y, Cakmak HB, Raza S, Anayol A, Asik E, Sim\u015fek S (2011) Short-term effects of intravitreal bevacizumab (Avastin(\u00ae)) on retrobulbar hemodynamics in patients with neovascular age-related macular degeneration. Acta Ophthalmol 89:e41\u2013e45","journal-title":"Acta Ophthalmol"},{"key":"1865_CR20","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1167\/iovs.10-5842","volume":"52","author":"S Sacu","year":"2011","unstructured":"Sacu S, Pemp B, Weigert G, Matt G, Garhofer G, Pruente C, Schmetterer L, Schmidt-Erfurth U (2011) Response of retinal vessels and retrobulbar hemodynamics to intravitreal anti-VEGF treatment in eyes with branch retinal vein occlusion. Invest Ophthalmol Vis Sci 52:3046\u20133050","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1865_CR21","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/j.1755-3768.2009.01612.x","volume":"88","author":"PK Kofoed","year":"2010","unstructured":"Kofoed PK, Munch IC, Larsen M (2010) Profound retinal ischaemia after ranibizumab administration in an eye with ocular ischaemic syndrome. Acta Ophthalmol 88:808\u2013810","journal-title":"Acta Ophthalmol"},{"key":"1865_CR22","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1755-3768.2008.01406.x","volume":"88","author":"T Hanno von","year":"2010","unstructured":"von Hanno T, Kinge B, Fossen K (2010) Retinal artery occlusion following intravitreal anti-VEGF therapy. Acta Ophthalmol 88:263\u2013266","journal-title":"Acta Ophthalmol"},{"key":"1865_CR23","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/j.1755-3768.2009.01535.x","volume":"88","author":"AM Mansour","year":"2010","unstructured":"Mansour AM, Bynoe LA, Welch JC, Pesavento R, Mahendradas P, Ziemssen F, Pai SA (2010) Retinal vascular events after intravitreal bevacizumab. Acta Ophthalmol 88:730\u2013735","journal-title":"Acta Ophthalmol"},{"key":"1865_CR24","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1111\/j.1755-3768.2008.01187.x","volume":"86","author":"K Yokoyama","year":"2008","unstructured":"Yokoyama K, Choshi T, Kimoto K, Shinoda K, Nakatsuka K (2008) Retinal circulatory disturbances following intracameral injection of bevacizumab for neovascular glaucoma. Acta Ophthalmol 86:927\u2013928","journal-title":"Acta Ophthalmol"},{"key":"1865_CR25","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000235726","volume":"224","author":"ZL Huang","year":"2010","unstructured":"Huang ZL, Lin KH, Lee YC, Sheu MM, Tsai RK (2010) Acute vision loss after intravitreal injection of bevacizumab (avastin) associated with ocular ischemic syndrome. Ophthalmologica 224:86\u201389","journal-title":"Ophthalmologica"},{"key":"1865_CR26","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ajo.2007.02.037","volume":"144","author":"L Amselem","year":"2007","unstructured":"Amselem L, Montero J, Diaz-Llopis M, Pulido JS, Bakri SJ, Palomares P, Garcia-Delpech S (2007) Intravitreal bevacizumab (Avastin) injection in ocular ischemic syndrome. Am J Ophthalmol 144:122\u2013124","journal-title":"Am J Ophthalmol"},{"key":"1865_CR27","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3341\/kjo.2009.23.2.132","volume":"23","author":"SJ Lee","year":"2009","unstructured":"Lee SJ, Lee JJ, Kim SY, Kim SD (2009) Intravitreal bevacizumab (Avastin) treatment of neovascular glaucoma in ocular ischemic syndrome. Korean J Ophthalmol 23:132\u2013134","journal-title":"Korean J Ophthalmol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-011-1865-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-011-1865-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-011-1865-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T21:03:22Z","timestamp":1560978202000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-011-1865-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,25]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["1865"],"URL":"https:\/\/doi.org\/10.1007\/s00417-011-1865-8","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,25]]}}}